Home/Filings/4/0001062993-24-016386
4//SEC Filing

Last Andrew J. 4

Accession 0001062993-24-016386

CIK 0000012208other

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 2:05 PM ET

Size

8.3 KB

Accession

0001062993-24-016386

Insider Transaction Report

Form 4
Period: 2024-09-06
Last Andrew J.
EVP, Chief Operating Officer
Transactions
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2024-09-063,0000 total
    Exercise: $299.24Exp: 2029-04-29Bio-Rad A Common Stock (3,000 underlying)
  • Exercise/Conversion

    Bio-Rad A Common Stock

    2024-09-06$299.24/sh+3,000$897,72010,559.45 total
  • Sale

    Bio-Rad A Common Stock

    2024-09-06$329.94/sh3,000$989,8157,559.45 total
Footnotes (1)
  • [F1]The option, representing a right to purchase a total of 5,000 shares, became exercisable in five equal annual installments beginning on April 29, 2019, which was the first anniversary of the date on which the option was granted.

Issuer

BIO-RAD LABORATORIES, INC.

CIK 0000012208

Entity typeother

Related Parties

1
  • filerCIK 0001485088

Filing Metadata

Form type
4
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 2:05 PM ET
Size
8.3 KB